Unicycive Therapeutics Inc

Research Unicycive Therapeutics Inc (UNCY) on Bullrun: market cap USD 205.59M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerUNCY
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 205.59M
• Financial periodFY2025
• Net income-USD 26.56M
• Free cash flow-USD 31.34M

Valuation Snapshot

latest market cap is USD 205.59M.

About Unicycive Therapeutics Inc

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis;

Frequently asked questions

What is Unicycive Therapeutics Inc's market cap?

Unicycive Therapeutics Inc's market capitalization is USD 205.59M.

What does Unicycive Therapeutics Inc do?

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States.